Upstream Bio (UPB) Current Leases (2023 - 2026)

Upstream Bio's quarterly Current Leases came in at $724000.0 in Q1 2026, up 2.26% year-on-year from $708000.0 in Q1 2025, and up 0.56% quarter-over-quarter from $720000.0 in Q4 2025.

Upstream Bio has reported Current Leases for 4 years, with the latest figure at $724000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 2.26% year-over-year to $724000.0; the trailing twelve-month figure through Mar 2026 stood at $724000.0 (up 2.26% YoY), and the FY2025 full-year result was $720000.0, up 2.27% from the prior year.
  • Current Leases for Q1 2026 stood at $724000.0, up from $720000.0 in the prior quarter.
  • The five-year high for Current Leases was $724000.0 in Q1 2026, with the low at $45000.0 in Q4 2023.
  • Average Current Leases over 4 years is $625875.0, with a median of $710000.0 recorded in 2025.
  • Year-over-year, Current Leases soared 1464.44% in 2024 and gained 2.26% in 2026.
  • Tracing UPB's Current Leases over 4 years: stood at $45000.0 in 2023, then soared by 1464.44% to $704000.0 in 2024, then increased by 2.27% to $720000.0 in 2025, then rose by 0.56% to $724000.0 in 2026.
  • The last three Current Leases figures came in at $724000.0 (Q1 2026), $720000.0 (Q4 2025), and $716000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 83,991.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 45.66 Mn
10 Upstream Bio 454.22 Mn 454.22 Mn -3.94 Mn 724,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 724,000.00
Dec 31, 2025 720,000.00
Sep 30, 2025 716,000.00
Jun 30, 2025 712,000.00
Mar 31, 2025 708,000.00
Dec 31, 2024 704,000.00
Sep 30, 2024 678,000.00
Dec 31, 2023 45,000.00